Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture.

Risner, Kenneth H; Tieu, Katie V; Wang, Yafei; Getz, Michael; Bakovic, Allison; Bhalla, Nishank; Nathan, Steven D; Conway, Daniel E; Macklin, Paul; Narayanan, Aarthi; Alem, Farhang

Risner, Kenneth H; Tieu, Katie V; Wang, Yafei; Getz, Michael; Bakovic, Allison; Bhalla, Nishank; Nathan, Steven D; Conway, Daniel E; Macklin, Paul; Narayanan, Aarthi; Alem, Farhang.

Afiliação

Risner KH; Center for Infectious Disease Research, George Mason University, Manassas, Virginia, United States of America.
Tieu KV; Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Wang Y; Intellegent Systems Engineering, Indiana University, Bloomington, Indiana, United States of America.
Getz M; Intellegent Systems Engineering, Indiana University, Bloomington, Indiana, United States of America.
Bakovic A; Center for Infectious Disease Research, George Mason University, Manassas, Virginia, United States of America.
Bhalla N; Center for Infectious Disease Research, George Mason University, Manassas, Virginia, United States of America.
Nathan SD; Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Fairfax, Virginia, United States of America.
Conway DE; Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Macklin P; Intellegent Systems Engineering, Indiana University, Bloomington, Indiana, United States of America.
Narayanan A; Center for Infectious Disease Research, George Mason University, Manassas, Virginia, United States of America.
Alem F; American Type Culture Collection, Manassas, Virginia, United States of America.